Jennifer Steger, PhD

Jennifer Steger, PhD has a diverse work experience spanning from 2008 to 2018. Jennifer began their professional career in 2008 as a Summer Research Student for the Juneau Icefield Research Program (JIRP) at the University of Alaska Southeast, where they developed and conducted an independent field research project to explore and characterize the existence of distinct microclimates on the Taku Glacier. In 2010, they then worked as a Research Assistant for UC Berkeley under the advisement of Dr. Richard S. Dodd. In this role, they designed and conducted experiments investigating the genetic susceptibility of Tanoak to the pathogen responsible for Sudden Oak Death. In 2011, they worked as an Honors Research Student for Brown University under the advisement of Dr. Eduardo A. Nillni. From 2013 to 2015, they worked as a Research Assistant for the Beth Israel Deaconess Medical Center/Harvard Medical School under the advisement of Dr. Bradford B. Lowell, where they contributed to the design and execution of experiments for several projects utilizing genetic engineering techniques in mice, in conjunction with optogenetics, pharmacogenetics (DREADDs), and rabies mapping, to elucidate discrete neural circuits controlling appetite and feeding behavior. Finally, in 2018, they began working as the Co-Founder and Chief Scientific Officer for Nanodropper, Inc.

Jennifer Steger, PhD, obtained their Bachelor of Science (B.Sc.) in Neuroscience with Honors from Brown University in 2013. Jennifer then went on to earn their Doctor of Philosophy (Ph.D.) in Pharmacology from the University of Washington in 2020.